Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer

Background: Therapy-related neuroendocrine prostate cancer (NEPC) is a lethal castration-resistant prostate cancer (CRPC) subtype that, at present, lacks well-characterized molecular biomarkers. The clinical diagnosis of this disease is dependent on biopsy and histological assessment: methods that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cuijian, Qian, Jinqin, Wu, Yucai, Zhu, Zhenpeng, Yu, Wei, Gong, Yanqing, Li, Xuesong, He, Zhisong, Zhou, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503838/
https://www.ncbi.nlm.nih.gov/pubmed/34646089
http://dx.doi.org/10.3389/pore.2021.1609968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503838/
https://www.ncbi.nlm.nih.gov/pubmed/34646089
http://dx.doi.org/10.3389/pore.2021.1609968

Ejemplares similares